3003 North First Street #221 — San Jose, California

3003 North First Street #221 is a clinical research site located in San Jose, California, United States 95134.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

3003 North First Street #221 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Thyroid Eye Disease (TED), Graves Ophthalmopathy, Thyroid Associated Ophthalmopathies.

Sponsors: THYROSCOPE INC..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Jose

Browse all research sites in California · View every site in San Jose

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 3003 North First Street #221?

3003 North First Street #221 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 3003 North First Street #221 conducted?

3003 North First Street #221 has 2 clinical trials on record, with 2 currently active. Their work covers Thyroid Eye Disease (TED), Graves Ophthalmopathy, Thyroid Associated Ophthalmopathies.

Is 3003 North First Street #221 accredited by Crixeo Clinical Trials?

3003 North First Street #221 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 3003 North First Street #221?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.